These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23541807)

  • 1. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
    Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
    Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
    Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.
    Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ
    J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.
    Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O
    Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
    Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
    Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.
    Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
    Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
    Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
    Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
    Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
    Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.
    Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
    Int J Oncol; 2017 Feb; 50(2):535-544. PubMed ID: 28035350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
    Qin Y; Ye J; Zhao F; Hu S; Wang S
    Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
    Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
    Liu JF; Tsao YT; Hou CH
    Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
    Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
    Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
    Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
    BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma.
    Yang M; Pan Y; Zhou Y
    Tumour Biol; 2015 Aug; 36(8):5965-70. PubMed ID: 25736924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of TRAF4 expression suppresses osteosarcoma cell growth in vitro and in vivo.
    Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
    Int J Mol Med; 2014 Dec; 34(6):1655-60. PubMed ID: 25270078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.
    Wang L; Liu W; Tang H; Xie X; Zou C; Wang Y; Gao Z; Yin J
    Cancer Med; 2017 May; 6(5):982-993. PubMed ID: 28374915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.